Trials / Completed
CompletedNCT01210391
Growth of Infants Fed an Extensively Hydrolyzed Infant Formula
Assessment of Growth of Infants Fed a 100% Whey Extensively Hydrolyzed Formula.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 282 (actual)
- Sponsor
- Société des Produits Nestlé (SPN) · Industry
- Sex
- All
- Age
- 11 Days – 4 Months
- Healthy volunteers
- Accepted
Summary
The primary objective of the clinical trial is to compare growth in infants (expressed as weight gain in g/day) consuming a new extensively hydrolyzed formula (EHF) to infants consuming a commercially available EHF.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Extensively hydrolyzed whey infant formula | New hydrolyzed infant formula. |
| OTHER | Extensively hydrolyzed casein infant formula | Commercially available infant formula. |
Timeline
- Start date
- 2010-11-01
- Primary completion
- 2013-07-01
- Completion
- 2013-07-01
- First posted
- 2010-09-28
- Last updated
- 2014-06-26
Locations
20 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01210391. Inclusion in this directory is not an endorsement.